Investigating how macrophages respond to hemolytic diseases like sickle cell disease and β-thalassemia

Macrophage Functional Response in Hemolytic Complications

['FUNDING_P01'] · NEW YORK BLOOD CENTER · NIH-10880429

This study is looking at how certain immune cells called macrophages react to the breakdown of red blood cells in sickle cell disease and β-thalassemia, to help find better treatments for people living with these conditions.

Quick facts

Phase['FUNDING_P01']
Study typeNih_funding
SexAll
SponsorNEW YORK BLOOD CENTER (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-10880429 on ClinicalTrials.gov

What this research studies

This research focuses on understanding the role of macrophages in hemolytic diseases, particularly sickle cell disease (SCD) and β-thalassemia (THAL). It aims to explore how different types of hemolysis affect inflammation levels in these conditions. By using mouse models, the researchers will compare the inflammatory responses of macrophages in SCD and THAL, examining how fresh and old red blood cell transfusions influence these responses. The goal is to uncover mechanisms that could lead to better treatment strategies for patients suffering from these diseases.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with sickle cell disease or β-thalassemia.

Not a fit: Patients with other types of hemolytic disorders not specifically related to SCD or THAL may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options for patients with hemolytic diseases, potentially reducing inflammation and associated complications.

How similar studies have performed: Previous research has shown promising results in understanding macrophage responses in hemolytic conditions, suggesting that this approach could yield valuable insights.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Babesia infection, Babesia parasite infection

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.